As of April 16, 2025, Taysha Gene Therapies (TSHA) has a market cap of $0.26 billion USD. According to our data, Taysha Gene Therapies is ranked No.6683 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 16, 2025 | $0.26 B |
-26.57%
|
Dec 31, 2024 | $0.35 B |
-2.26%
|
Dec 29, 2023 | $0.36 B |
-21.68%
|
Dec 30, 2022 | $0.46 B |
-80.60%
|
Dec 31, 2021 | $2.39 B |
-56.10%
|
Dec 31, 2020 | $5.44 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Sarepta Therapeutics
SRPT
|
$5.28 B |
-0.000 M
|
![]() USA
|
![]() REGENXBIO
RGNX
|
$0.33 B |
-0.000 M
|
![]() USA
|
![]() Voyager Therapeutics
VYGR
|
$0.18 B |
-0.000 M
|
![]() USA
|
![]() uniQure
QURE
|
$0.52 B |
0.000 M
|
![]() Netherlands
|
![]() Adverum Biotechnologies
ADVM
|
$67.19 M |
-0.000 M
|
![]() USA
|
![]() Editas Medicine
EDIT
|
$0.11 B |
0.000 M
|
![]() USA
|
![]() Intellia Therapeutics
NTLA
|
$0.76 B |
-0.000 M
|
![]() USA
|
![]() bluebird bio
BLUE
|
$43.76 M |
0.000 M
|
![]() USA
|
![]() Solid Biosciences
SLDB
|
$0.21 B |
0.000 M
|
![]() USA
|
![]() MeiraGTx
MGTX
|
$0.43 B |
0.000 M
|
![]() USA
|
![]() Passage Bio
PASG
|
$22.93 M |
0.000 M
|
![]() USA
|
![]() Generation Bio
GBIO
|
$24.65 M |
0.000 M
|
![]() USA
|
Market Cap | = | TSHA Stock Price | * | TSHA Shares Outstanding |
= | $1.27 | * | 0.21 B | |
= | $0.26 B |